Publications by authors named "N Broman"

Article Synopsis
  • * The number of GD diagnoses rose significantly during this period, with a 1000% increase in legal gender changes from 2005 to 2018, indicating a notable trend in how individuals are navigating their gender identity.
  • * The study emphasizes the importance of understanding the factors driving these trends and suggests that healthcare systems need to adapt to meet the increasing demand for GD-related services.
View Article and Find Full Text PDF
Article Synopsis
  • Hospitals are offering outpatient parenteral antimicrobial therapy (OPAT) to cut costs, but they typically prefer broad-spectrum antibiotics over penicillin.
  • A study of 462 patients treated for erysipelas showed that using electronic continuous infusion pumps (eCIPs) increased the likelihood of penicillin use significantly.
  • Patients treated with eCIPs not only had a higher chance of receiving penicillin but also exhibited better clinical outcomes and higher satisfaction among both patients and nurses, suggesting eCIPs could be beneficial for promoting penicillin use and tackling antimicrobial resistance.
View Article and Find Full Text PDF

Background: In Turku, Finland, we introduced a home oxygen treatment and app-based monitoring program for hospitalized COVID-19 patients to facilitate an early discharge during the Omicron wave. In this case series we explore the clinical parameters of patients enrolled in the program and evaluate the cost-benefit and safety issues of the program.

Methods: Hospitalized COVID-19 patients with marked hypoxemia but otherwise in stable condition were screened from Turku City Hospital and Turku University Hospital by treating doctors for eligibility in the program.

View Article and Find Full Text PDF
Article Synopsis
  • - A study examined how blood levels of the myxovirus resistance protein A (MxA) correlate with the severity of COVID-19 in 304 hospitalized patients, focusing on those with recorded MxA levels.
  • - Results indicated that higher MxA levels (≥800 μg/L) were linked to more severe disease and a greater need for respiratory support and corticosteroids during hospitalization.
  • - The findings suggest that MxA levels could serve as a useful biomarker for predicting COVID-19 severity, potentially aiding in patient management.
View Article and Find Full Text PDF